as04
Small moleculeexperimental
Clinical trial activity
11 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
10
Phase 3
8
Phase 4
0
Earliest trial started Nov 1, 2003 (NCT00120848)
Timeline
Indications
Mechanism of action
- UnclearImmunity, active
Unclear immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- as04
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05561673 | Phase 1/Phase 2 (Phase 2) | Oct 4, 2022 | GlaxoSmithKline |
| NCT00572000 | N/A | Nov 1, 2007 | National Institute for Control of Vaccine and Biologicals |
| NCT00485732 | Phase 3 | Jun 1, 2007 | GlaxoSmithKline |
| NCT00345878 | Phase 3 | Sep 1, 2006 | GlaxoSmithKline |
| NCT00344032 | Phase 3 | Jul 1, 2006 | GlaxoSmithKline |
| NCT00306241 | Phase 3 | Mar 1, 2006 | GlaxoSmithKline |
| NCT00290277 | Phase 3 | Nov 1, 2005 | GlaxoSmithKline |
| NCT00169494 | Phase 3 | Sep 1, 2004 | GlaxoSmithKline |
| NCT00196924 | Phase 3 | Jun 1, 2004 | GlaxoSmithKline |
| NCT00128661 | Phase 3 | Jun 1, 2004 | GlaxoSmithKline |
| NCT00120848 | Phase 2 | Nov 1, 2003 | GlaxoSmithKline |
Showing 11 of 11 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 10 | 10 | 2 | 2003 |
| National Institute for Control of Vaccine and Biologicals | Government | 1 | 1 | 1 | 2007 |
2 organizations
Page 1 / 1